Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?

Recent financial analyses evaluate several healthcare stocks to determine the best investment opportunities for 2026. The comparisons focus on the potential growth and value of Amgen versus Moderna, as well as Axsome Therapeutics versus Viking Therapeutics. These evaluations aim to guide investors by analyzing the competitive positioning and future prospects of these specific companies within the healthcare sector, helping stakeholders decide which stocks offer superior long-term returns as they approach the 2026 fiscal period.